# Imax Corp: overview

IMAX · NYSE · CIK 921582 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/imax.md) · [Financials](/companies/imax/financials.md) · [Filings](/companies/imax/filings.md) · [Insiders](/companies/imax/insiders.md)

Latest reported revenue: [$102.8m](/filings/0001628280-26-049300.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Jul 23, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001628280-26-049300).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [91.5](/filings/0001628280-25-045982.md) | [92.7 d](/filings/0001628280-26-011770.md) | [86.7](/filings/0001628280-26-028960.md) | [91.7](/filings/0001628280-26-049300.md) | [107](/filings/0001628280-25-045982.md) | [125 d](/filings/0001628280-26-011770.md) | [81.4](/filings/0001628280-26-028960.md) | [103](/filings/0001628280-26-049300.md) |
| Gross margin | % | [55.8%](/filings/0001628280-25-045982.md) | [52.2% d](/filings/0001628280-26-011770.md) | [61.4%](/filings/0001628280-26-028960.md) | [58.5%](/filings/0001628280-26-049300.md) | [63.1%](/filings/0001628280-25-045982.md) | [57.6% d](/filings/0001628280-26-011770.md) | [56.3%](/filings/0001628280-26-028960.md) | [61.2%](/filings/0001628280-26-049300.md) |
| Operating margin | % | [21.2%](/filings/0001628280-25-045982.md) | [10.3% d](/filings/0001628280-26-011770.md) | [19.3%](/filings/0001628280-26-028960.md) | [15.6%](/filings/0001628280-26-049300.md) | [27.2%](/filings/0001628280-25-045982.md) | [19.3% d](/filings/0001628280-26-011770.md) | [12.2%](/filings/0001628280-26-028960.md) | [20.2%](/filings/0001628280-26-049300.md) |
| Net margin | % | [15.2%](/filings/0001628280-25-045982.md) | [5.7% d](/filings/0001628280-26-011770.md) | [2.7%](/filings/0001628280-26-028960.md) | [12.3%](/filings/0001628280-26-049300.md) | [19.4%](/filings/0001628280-25-045982.md) | [0.5% d](/filings/0001628280-26-011770.md) | [5.2%](/filings/0001628280-26-028960.md) | [15.0%](/filings/0001628280-26-049300.md) |
| Diluted EPS | $ per share | [0.26](/filings/0001628280-25-045982.md) | not reported | [0.04](/filings/0001628280-26-028960.md) | [0.20](/filings/0001628280-26-049300.md) | [0.37](/filings/0001628280-25-045982.md) | not reported | [0.07](/filings/0001628280-26-028960.md) | [0.27](/filings/0001628280-26-049300.md) |
| Free cash flow | $m | [34.2 d](/filings/0001628280-25-045982.md) | [6.9 d](/filings/0001628280-26-011770.md) | [5.3](/filings/0001628280-26-028960.md) | [20.9 d](/filings/0001628280-26-049300.md) | [64.8 d](/filings/0001628280-25-045982.md) | [28.0 d](/filings/0001628280-26-011770.md) | [1.9](/filings/0001628280-26-028960.md) | [32.0 d](/filings/0001628280-26-049300.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [255](/filings/0000950170-24-021327.md) | [301](/filings/0000921582-25-000008.md) | [375](/filings/0001628280-26-011770.md) | [352](/filings/0001628280-26-011770.md) | [410](/filings/0001628280-26-011770.md) |
| Gross margin | % | [52.7%](/filings/0000950170-24-021327.md) | [52.0%](/filings/0000921582-25-000008.md) | [57.2%](/filings/0001628280-26-011770.md) | [54.0%](/filings/0001628280-26-011770.md) | [60.0%](/filings/0001628280-26-011770.md) |
| Operating margin | % | [4.3%](/filings/0000950170-24-021327.md) | [(1.6%)](/filings/0000921582-25-000008.md) | [13.4%](/filings/0001628280-26-011770.md) | [12.5%](/filings/0001628280-26-011770.md) | [20.5%](/filings/0001628280-26-011770.md) |
| Net margin | % | [(8.8%)](/filings/0000950170-24-021327.md) | [(7.6%)](/filings/0000921582-25-000008.md) | [6.8%](/filings/0001628280-26-011770.md) | [7.4%](/filings/0001628280-26-011770.md) | [8.5%](/filings/0001628280-26-011770.md) |
| Diluted EPS | $ per share | [(0.38)](/filings/0000950170-24-021327.md) | [(0.40)](/filings/0000921582-25-000008.md) | [0.46](/filings/0001628280-26-011770.md) | [0.48](/filings/0001628280-26-011770.md) | [0.63](/filings/0001628280-26-011770.md) |
| Free cash flow | $m | [2.5](/filings/0000950170-24-021327.md) | [8.9](/filings/0000921582-25-000008.md) | [52.1](/filings/0001628280-26-011770.md) | [62.4](/filings/0001628280-26-011770.md) | [119](/filings/0001628280-26-011770.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/imax/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Orbis Allan Gray Ltd](/funds/1663865.md) | 2026-06-30 | $205.3m | 5,149,555 |  | Reduced −2,166 |
| [NOMURA ASSET MANAGEMENT INTERNATIONAL INC.](/funds/921739.md) | 2026-06-30 | $117.1m | 2,936,661 |  | Reduced −767,546 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $115.9m | 2,907,192 |  | Added +284,602 |
| [WESTFIELD CAPITAL MANAGEMENT CO LP](/funds/1177719.md) | 2026-06-30 | $105.8m | 2,654,014 |  | Added +315,238 |
| [CONGRESS ASSET MANAGEMENT CO](/funds/897378.md) | 2026-06-30 | $101.1m | 2,537,290 |  | Added +1,026,915 |
| [Driehaus Capital Management LLC](/funds/938206.md) | 2026-06-30 | $93.3m | 2,340,475 |  | Added +688,764 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $92.6m | 2,322,400 |  | Reduced −794,974 |
| [AMERIPRISE FINANCIAL INC](/funds/820027.md) | 2026-06-30 | $70.6m | 1,771,297 |  | Added +442,702 |
| [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $66.0m | 1,655,086 |  | Added +785,974 |
| [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $58.8m | 1,450,626 |  | Added +480,056 |

## Recent filings

[All 1,354 filings](/companies/imax/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-21 | 20:11 ET | [8-K](/filings/0001628280-26-058427.md) | 5.02 Departure or appointment of officers or directors | 0001628280-26-058427 |
| 2026-07-23 | 12:47 ET | [10-Q](/filings/0001628280-26-049300.md) | Quarterly report, period 2026-06-30 | 0001628280-26-049300 |
| 2026-07-23 | 12:05 ET | [8-K](/filings/0001628280-26-049290.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-049290 |
| 2026-06-11 | 20:13 ET | [8-K](/filings/0001628280-26-042508.md) | 5.07 Shareholder vote results | 0001628280-26-042508 |
| 2026-04-30 | 20:45 ET | [10-Q](/filings/0001628280-26-028960.md) | Quarterly report, period 2026-03-31 | 0001628280-26-028960 |
| 2026-04-30 | 20:16 ET | [8-K](/filings/0001628280-26-028907.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-028907 |
| 2026-04-24 | 20:19 ET | [DEF 14A](/filings/0001628280-26-027220.md) | Proxy statement, period 2026-06-10 | 0001628280-26-027220 |
| 2026-04-17 | 20:17 ET | [8-K](/filings/0001628280-26-025752.md) | 5.02 Departure or appointment of officers or directors | 0001628280-26-025752 |
| 2026-03-30 | 21:33 ET | [8-K](/filings/0001628280-26-022043.md) | 7.01 Regulation FD disclosure | 0001628280-26-022043 |
| 2026-03-17 | 21:00 ET | [SCHEDULE 13D/A](/filings/0001193125-26-111118.md) | Ownership report, active investor, amended | 0001193125-26-111118 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-011770.md), filed Feb 25, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/db719ef9-980d-417d-ab05-da509cb95bcb)

## About the filer

- CIK: 921582
- Tickers: IMAX
- Exchange: NYSE
- SIC code: 3861 Photographic Equipment & Supplies
- State of incorporation: A6
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.